Advances on Prevention and Treatment of Human Respiratory Syncytial Virus
Respiratory syncytial virus(RSV)is a leading cause of respiratory and lung infections,especially in young children and the elderly,which are prone to serious infections.Despite the global impact of RSV infection on healthcare,the current ther-apy is still mostly supportive.Over the past few decades,our understanding of the pathogenesis and immunopathology of RSV had evolved,leading to significant advances in RSV prevention strategies.More than 50 years have passed since the RSV vac-cine was first trialed in 1966,and two RSV vaccines have been approved.In this paper,current treatment options for RSV infec-tion(including RSV-specific and non-specific)and the development progress of different RSV prevention vaccines were re-viewed,which was expected to provide reference for the treatment and vaccines research and development of RSV.
万方数据
维普
